这只个股，今年以来涨超290%

Market Overview - A-shares showed mixed performance with over 2300 stocks rising, while the Shanghai Composite Index increased by 0.01%, the Shenzhen Component decreased by 0.11%, and the ChiNext Index rose by 0.26% [1] - The total market turnover was approximately 1.3 trillion yuan, an increase of 169 billion yuan compared to the previous trading day [1] Gold Sector - Gold concept stocks experienced a strong rally, with Hengbang Co. hitting the daily limit and Chao Hong Ji rising over 8%. In the Hong Kong market, Lao Pu Gold surged over 7% and has increased by over 290% year-to-date [5][1] - Lao Pu Gold launched new products, including the "Hulu Baby" and "Seven Sons Hulu" series, which have resonated with customers and showcased the brand's innovation in product design and craftsmanship [8] - The company is expanding its retail presence with new stores in high-profile locations, which is expected to enhance brand influence and improve customer experience [8] Innovative Drug Sector - The innovative drug sector saw significant gains, with Bai Jie Shen Zhou rising 8% to reach a historical high, and other stocks like Hai Si Ke and Ao Sai Kang hitting the daily limit [10] - In the Hong Kong market, Rongchang Biotechnology surged over 20% and China Biopharmaceutical rose over 19%, with the Heng Seng Innovative Drug ETF increasing by 4.34% [10] - China Biopharmaceutical's management announced collaborations with multinational pharmaceutical companies, indicating strong commercial potential for innovative assets [10] - A recent policy document aims to improve the medical insurance drug list, which is expected to enhance access to innovative drugs for the public [10] - The pharmaceutical sector is projected to see its first profit upturn in three years by Q1 2025, driven by the rapid development of innovative drugs and their associated value releases [11]